Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhangyu Zou

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Clinical Immunology (Orlando, Fla.)|August 23, 2025
Efgartigimod versus standard of care in new-Onset AChR subtype generalized myasthenia gravis: A prospective cohort studyDingxian He, Lei Jin, Shuangshuang Wang, et al.
Neurology and Therapy|June 27, 2026
Extended Preoperative Immunotherapy Duration Reduces the Risk of Myasthenia Gravis Exacerbation for Patients with Thymoma: A Multicenter Retrospective Cohort StudyJialin Chen, Hongxi Chen, Xianglin Chu, et al.
Clinical Immunology (Orlando, Fla.)|December 24, 2023
Clinical outcome and peripheral immune profile of myasthenic crisis with omicron infections: A prospective cohort studyXiao Huan, Jialin Chen, Huahua Zhong, et al.
Neuromuscular Disorders : NMD|October 2, 2023
Myasthenic crisis in thymoma-associated myasthenia gravis: a multicenter retrospective cohort studyXiao Huan, Zhe Ruan, Rui Zhao, et al.
Journal of Neuroimmunology|March 7, 2025
Clinical outcome and peripheral CD4<sup>+</sup> T profile in impending myasthenic crisis: A prospective cohort studyYuan Wang, Xiao Huan, Jie Song, et al.
Neurology and Therapy|April 12, 2022
Therapeutic Effects of Batoclimab in Chinese Patients with Generalized Myasthenia Gravis: A Double-Blinded, Randomized, Placebo-Controlled Phase II StudyChong Yan, Rui-Sheng Duan, Huan Yang, et al.
Therapeutic Advances in Neurological Disorders|December 30, 2024
Eculizumab in thymoma-associated myasthenia gravis: a real-world cohort studyLei Jin, Dingxian He, Quantao Zeng, et al.
Annals of Clinical and Translational Neurology|July 8, 2024
Efgartigimod for generalized myasthenia gravis: A multicenter real-world cohort study in ChinaSushan Luo, Qilong Jiang, Wenshuang Zeng, et al.
JAMA Network Open|February 24, 2025
Tetramethylpyrazine Nitrone in Amyotrophic Lateral Sclerosis: A Randomized Clinical TrialXiaolu Liu, Huifang Shang, Qianqian Wei, et al.
Therapeutic Advances in Neurological Disorders|February 20, 2025
Patterns and predictors of therapeutic response to efgartigimod in acetylcholine receptor-antibody generalized myasthenia gravis subtypesLei Jin, Zhangyu Zou, Qinzhou Wang, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Clinical Immunology (Orlando, Fla.)|August 23, 2025
Efgartigimod versus standard of care in new-Onset AChR subtype generalized myasthenia gravis: A prospective cohort studyDingxian He, Lei Jin, Shuangshuang Wang, et al.
Neurology and Therapy|June 27, 2026
Extended Preoperative Immunotherapy Duration Reduces the Risk of Myasthenia Gravis Exacerbation for Patients with Thymoma: A Multicenter Retrospective Cohort StudyJialin Chen, Hongxi Chen, Xianglin Chu, et al.
Clinical Immunology (Orlando, Fla.)|December 24, 2023
Clinical outcome and peripheral immune profile of myasthenic crisis with omicron infections: A prospective cohort studyXiao Huan, Jialin Chen, Huahua Zhong, et al.
Neuromuscular Disorders : NMD|October 2, 2023
Myasthenic crisis in thymoma-associated myasthenia gravis: a multicenter retrospective cohort studyXiao Huan, Zhe Ruan, Rui Zhao, et al.
Journal of Neuroimmunology|March 7, 2025
Clinical outcome and peripheral CD4<sup>+</sup> T profile in impending myasthenic crisis: A prospective cohort studyYuan Wang, Xiao Huan, Jie Song, et al.
Neurology and Therapy|April 12, 2022
Therapeutic Effects of Batoclimab in Chinese Patients with Generalized Myasthenia Gravis: A Double-Blinded, Randomized, Placebo-Controlled Phase II StudyChong Yan, Rui-Sheng Duan, Huan Yang, et al.
Therapeutic Advances in Neurological Disorders|December 30, 2024
Eculizumab in thymoma-associated myasthenia gravis: a real-world cohort studyLei Jin, Dingxian He, Quantao Zeng, et al.
Annals of Clinical and Translational Neurology|July 8, 2024
Efgartigimod for generalized myasthenia gravis: A multicenter real-world cohort study in ChinaSushan Luo, Qilong Jiang, Wenshuang Zeng, et al.
JAMA Network Open|February 24, 2025
Tetramethylpyrazine Nitrone in Amyotrophic Lateral Sclerosis: A Randomized Clinical TrialXiaolu Liu, Huifang Shang, Qianqian Wei, et al.
Therapeutic Advances in Neurological Disorders|February 20, 2025
Patterns and predictors of therapeutic response to efgartigimod in acetylcholine receptor-antibody generalized myasthenia gravis subtypesLei Jin, Zhangyu Zou, Qinzhou Wang, et al.
Pageof 3